THE TRANSCRIPTION FACTORS IKZF1 AND IKZF3 CONTROL B CELL ACTIVATION AND DIFFERENTIATION IN SYSTEMIC LUPUS ERYTHEMATOSUS

被引:1
|
作者
Manou-Stathopoulou, Sotiria [1 ]
Rivellese, Felice [1 ]
Mauro, Daniele [1 ]
Goldmann, Katriona [1 ]
Pyne, Debasish [2 ]
Schafer, Peter [3 ]
Bombardieri, Michele [1 ]
Pitzalis, Costantino [1 ]
Lewis, Myles [1 ]
机构
[1] Queen Mary Univ London, William Harvey Res Inst, Expt Med & Rheumatol, London, England
[2] Barts Hlth NHS Trust, Rheumatol, London, England
[3] Celgene Corp, Summit, NJ USA
关键词
D O I
10.1136/annrheumdis-2019-eular.6343
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0179
引用
收藏
页码:1548 / 1548
页数:1
相关论文
共 50 条
  • [1] Triple Degradation of BTK, IKZF1 and IKZF3 in B-Cell Malignancies
    Morrow, Sara
    Dobrovolsky, Dennis
    Wang, Eric
    Nowak, Radoslaw P.
    Donovan, Katherine
    Faust, Tyler
    Yang, Guang
    Li, Zhengnian
    Fischer, Eric
    Treon, Steven P.
    Weinstock, David M.
    Gray, Nathanael S.
    BLOOD, 2018, 132
  • [2] Lenalidomide induces degradation of IKZF1 and IKZF3
    Kroenke, Jan
    Hurst, Slater N.
    Ebert, Benjamin L.
    ONCOIMMUNOLOGY, 2014, 3 (07)
  • [3] IKZF1: a critical role in the pathogenesis of systemic lupus erythematosus?
    Hu, Su-juan
    Wen, Lei-lei
    Hu, Xin
    Yin, Xian-yong
    Cui, Yong
    Yang, Sen
    Zhang, Xue-jun
    MODERN RHEUMATOLOGY, 2013, 23 (02) : 205 - 209
  • [4] THE TRANSCRIPTION FACTORS IKAROS (IKZF1) AND AIOLOS (IKZF3) ARE EXPRESSED IN THE SALIVARY GLANDS OF SJOGREN'S SYNDROME PATIENTS WITH LYMPHOID AGGREGATES AND MODULATE B CELL ACTIVATION IN VITRO
    Rivellese, Felice
    Manou-Stathopoulou, Sotiria
    Mauro, Daniele
    Pontarini, Elena
    Lucchesi, Davide
    Congia, Mattia
    Schafer, Peter
    Sutcliffe, Nurhan
    Pitzalis, Costantino
    Lewis, Myles
    Bombardieri, Michele
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 394 - 395
  • [5] ALLELE-SPECIFIC BINDING DIFFERENCES OF FOX TRANSCRIPTION FACTORS TO IKZF3 RISK ALLELES IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Graham, D. Cunninghame
    Cortini, A.
    Odhams, C.
    Vyse, T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S16 - S16
  • [6] Trans-Ancestral Fine-Mapping and Epigenetic Annotation as Tools to Delineate Functionally Relevant Risk Alleles at IKZF1 and IKZF3 in Systemic Lupus Erythematosus
    Vyse, Timothy J.
    Graham, Deborah S. Cunninghame
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 45
  • [7] Lenalidomide Promotes CRBN-Mediated Ubiquitination and Degradation of IKZF1 and IKZF3
    Kroenke, Jan
    Udeshi, Namrata
    Narla, Anupama
    Grauman, Peter
    Hurst, Slater
    McConkey, Marie
    Svinkina, Tanya
    Heckl, Dirk
    Comer, Eamon
    Li, Xiaoyu
    Ciarlo, Christie
    Hartman, Emily
    Schenone, Monica
    Schreiber, Stuart
    Carr, Steven A.
    Ebert, Benjamin L.
    BLOOD, 2013, 122 (21)
  • [8] Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
    Kroenke, Jan
    Udeshi, Namrata D.
    Narla, Anupama
    Grauman, Peter
    Hurst, Slater N.
    McConkey, Marie
    Svinkina, Tanya
    Heckl, Dirk
    Comer, Eamon
    Li, Xiaoyu
    Ciarlo, Christie
    Hartman, Emily
    Munshi, Nikhil
    Schenone, Monica
    Schreiber, Stuart L.
    Carr, Steven A.
    Ebert, Benjamin L.
    SCIENCE, 2014, 343 (6168) : 301 - 305
  • [9] ASSOCIATION OF IKZF3 GENE POLYMORPHISM WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN THE GUIZHOU HAN POPULATION
    Yang Ying
    Chen Lin
    Liang Han Yue
    Chen Xiaohong
    Liu Jun
    ACTA MEDICA MEDITERRANEA, 2020, 36 (06): : 3361 - +
  • [10] Beta-Catenin Forms Repressive Complexes with Ikzf1 and Ikzf3 to Orchestrate Tumor-Suppression in B-Cell Malignancies
    Cosgun, Kadriye Nehir
    Robinson, Mark E.
    Chan, Lai N.
    Hur, Matthew
    Leveille, Etienne
    Song, Joo
    Chan, Wing C.
    Muschen, Markus
    BLOOD, 2021, 138